Aldeyra Therapeutics's total assets for Q3 2024 were $117.32M, a decrease of -6.92% from the previous quarter. ALDX total liabilities were $32.22M for the fiscal quarter, a 16.19% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.